Concepedia

A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin

Jhanelle E. Gray, Jeffrey R. Infante, Les Brail, George R. Simon, Jennifer F Cooksey, Suzanne F. Jones, Daphne L. Farrington, Adeline Yeo, Kimberley Jackson, Kay Hoong Chow,

Investigational New Drugs · 2015 · 73 citations · 17 references

DOI

Concepts

References

17

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

Binhua P. Zhou, Jiong Deng, Weiya Xia et al. · Nature Cell Biology · 2004 · 1.6K citations

, , +16

Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009

Yan Xu, Hongyu Liu, Jun Chen et al. · Thoracic Cancer · 2010 · 890 citations

, , +9

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

Michael Byrne, Anna K. Nowak · Annals of Oncology · 2004 · 646 citations · Full text

, , +9

Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription

Robin E. Bachelder, Sang-Oh Yoon, Clara Francı́ et al. · The Journal of Cell Biology · 2005 · 384 citations · Full text

, , +16